Influence of Biliblanket Treatment on Admission for Overhead Phototherapy in Term Infants Approaching the Treatment Line - A Randomised Controlled Trial

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Purpose: To evaluate if biliblankets prevents the need for overhead phototherapy in neonates with physiological jaundice approaching the treatment line. Methods: Single-centre randomised trial carried out in a tertiary maternity unit. Infants ≥35 weeks gestation and >24 hours of age with suspected physiological jaundice were eligible if serum bilirubin level was within 35µmol/l of the treatment line. Infants admitted to the neonatal unit or with a positive pre-randomisation direct Coombs test were excluded. Infants were randomised to intervention arm (treatment with Biliblanket) or control arm (routine care). Primary outcome was need for overhead phototherapy. Results: Ninety-seven infants were included in an intention-to-treat analysis, 51 in intervention arm and 46 in control arm with no baseline imbalances. Sixteen percent in the intervention group and 15% in the control group required overhead phototherapy (p>0.99) and no difference in length of stay (p=0.6) was observed. More infants in the intervention arm were discharged receiving formula feeds exclusively (p=0.04) despite no difference in feeding intentions. Conclusion: Use of a biliblanket for physiological jaundice approaching the treatment line in well term infants does not decrease need for overhead phototherapy with no difference in length of stay, but a potential for disruption of breastfeeding establishment. Trial Registration: The trial was retrospectively registered (ISRCTN29045982 - https://www.isrctn.com/) on 08/01/2022.

Article activity feed